NIH busca opiniones sobre cómo apoyar la investigación clínica y translacional en Puerto Rico (y otros estados IDeA)

Giovanna Guerrero-Medina's picture

Forums: 

Enlace: http://grants.nih.gov/grants/guide/notice-files/NOT-RR-10-010.html Descripción: El Instituto Nacional de Recursos de Investigación (NCRR por sus siglas en inglés; parte del NIH) está buscando opiniones del público interesado sobre cómo apoyar la investigación clínica y translacional en instituciones que forman parte del programa "IDeA" (Institutional Development Award). Varias universidades puertorriqueñas forman parte de este programa que abarca subprogramas como: 1. Centers of Biomedical Research Excellence (COBRE) a. Center for Molecular, Developmental and Behavioral Neuroscience, UPR-RCM b. UPR Protein Research Center, UPR-RUM 2. IDeA Networks of Biomedical Research Excellence (INBRE) a. Advancing Competitive Biomedical Research in Puerto Rico (Sistema UPR entero, UCC, UMet, Turabo, PSM, Inter, etc.) Ademas de estos programas, NCRR tiene varios programas de recursos que podrían apoyar la inevstigación clínica y translacional (e.g. RCMI, National Primate Research Center-NPRC, Biomedical Informatics Research Network-BIRN, Biomedical Technology Research Centers-BTRCs, etc) varios de los cuales tienen centros/proyectos en Puerto Rico. Por medio de este RFI NIH busca opiniones sobre las preguntas listadas abajo. Favor mandar respuestas a taylorwf@nih.gov con información sobre que organización representa y su rol en esta organización. Preguntas: 1) Interest in clinical and/or translational research Comment on the relative importance of clinical and translational research within the overall context of biomedical and behavioral research at your institution and within your state generally. This may include emerging plans, if any, to increase the amount of clinical and/or translational research at your institution over the next few years, your interest in submitting applications for NIH funding to conduct such research and opportunities to conduct clinical and translational research focusing on health disparities in rural and other medically underserved communities. 2) The current infrastructure for conducting clinical and translational research at your institution This could include but is not limited to a critical mass of investigators with expertise in clinical and/or translational research; physician scientists who are willing to participate in such research; clinical research education and training programs; availability of participants in research involving human subjects; access to diverse populations; Institutional Review Boards and regulatory support services for research involving human subjects; institutional interest in and support for clinical research, including clinical research space, equipment and release time for physicians and other clinical practitioners. 3) Key challenges to conducting clinical and/or translational research at your institution These could include but are not limited to a lack of a critical mass of investigators with appropriate expertise; inadequate regulatory support for research involving human subjects; limited access to patient or participant populations; inadequate facilities and/or equipment; difficulty obtaining sufficient clinical release time for clinician scientists; limited access to or support for clinical research education and training opportunities or the need for collaboration with colleagues. 4) Key infrastructure enhancements and/or programmatic initiatives that could significantly enhance your ability to conduct clinical and/or translational research at your institution This could include but is not limited to enhancements to institutional research training and career development efforts; improved coordination and synergy between clinical and translational research and training activities; collaborations across institutions within and between IDeA states; opportunities to leverage clinical and translational research resources, expertise and programs at other institutions, including those in non-IDeA states, such as NCRR-supported BBTRCs, NPRCs and other animal model resources, CTSA sites, RCMI sites and the RCMI Translational Research Network. 5) Issues associated with the extant COBRE initiative The current phase-I Centers of Biomedical Research Excellence (COBRE) initiative supported by the IDeA program places significant emphasis on mentoring and career development of junior investigators. Comments are welcome on the advantages or disadvantages such an emphasis may present in the context of developing a clinical research center at your institution. This may include the key components that should be supported in order to develop or strengthen clinical and translational research centers using the existing COBRE mechanism. 6) Other issues Please feel free to offer comment on any other issues pertaining to research infrastructure that may influence, positively or negatively, the ability to conduct clinical and translational research in institutions within IDeA states. These comments may include any other issues that may affect the ability of investigators to compete independently for peer-reviewed support to conduct clinical and translational research.

Rating: 

0

Tags: